Hemodialysis for toxic hypermagnesemia caused by intravenous magnesium in a woman with eclampsia and renal insufficiency. A case report.
BACKGROUND
Toxic hypermagnesemia is a wellknown adverse effect of intravenous magnesium.


METHODS
A woman with postpartum eclampsia was treated with intravenous magnesium at another hospital and then transferred to our hospital due to cardiopulmonary failure. Blood magnesium and creatinine levels were markedly elevated. Hemodialysis rapidly improved her condition.


CONCLUSIONS
Hemodialysis is effective for toxic hypermagnesemia caused by intravenous magnesium in a case of severe renal insufficiency.
Hirose
Masaya
M
Department of Obstetrics and Gynecology, Shiga University of Medical Science, Setatsukinowa, Ohtsu 520-2192, Japan. hirose@belle.shiga-med.ac.jp
Kobayashi
Masashi
M
Sudo
Shinsuke
S
Nakanishi
Keiko
K
Noda
Yoichi
Y
D000328:Adult; D002318:Cardiovascular Diseases / Q000209:etiology; D004461:Eclampsia / Q000628:therapy*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008274:Magnesium / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D049590:Postpartum Period; D011247:Pregnancy; D006435:Renal Dialysis; D051437:Renal Insufficiency / Q000150:complications*; D016896:Treatment Outcome
D008274:Magnesium